Literature DB >> 17002687

The CX3CL1-CX3CR1 system and psoriasis.

Darren Plant1, Helen S Young, Rachel E B Watson, Jane Worthington, Christopher E M Griffiths.   

Abstract

CX3CL1 is a chemoattractant and adhesion molecule that induces the redistribution of CX3CR1-positive inflammatory leucocytes to sites of inflammation. As a consequence of their increased expression in plaques of psoriasis, and location within genomic regions previously linked to this disease, CX3CL1, and its receptor CX3CR1, represent attractive positional and functional 'psoriasis susceptibility genes'. To investigate the CX3CL1-CX3CR1 system in psoriasis, eight single nucleotide polymorphisms (SNPs) in CX3CL1 and two SNPs in CX3CR1 were genotyped in 281 psoriasis patients and 184 unrelated controls. Allele, genotype and estimated haplotype frequencies were then compared between experimental groups. Allele frequency differences between healthy volunteers and psoriasis patients revealed associations with two CX3CR1 SNPs (hCV11578468, P = 0.03 and c_5687_1, P = 0.04). No associations were observed between CX3CL1 SNPs and psoriasis. These results support a role for the CX3CL1-CX3CR1 system in the pathogenesis of psoriasis and identify SNPs within the chemokine receptors that are associated with the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002687     DOI: 10.1111/j.1600-0625.2006.00486.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

Review 1.  Psoriasis: what we have learned from mouse models.

Authors:  Erwin F Wagner; Helia B Schonthaler; Juan Guinea-Viniegra; Erwin Tschachler
Journal:  Nat Rev Rheumatol       Date:  2010-09-28       Impact factor: 20.543

Review 2.  CCR6 as a possible therapeutic target in psoriasis.

Authors:  Michael N Hedrick; Anke S Lonsdorf; Sam T Hwang; Joshua M Farber
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

3.  Genetic background of psoriasis.

Authors:  Hani A Alshobaili; Muhammad Shahzad; Abdullah Al-Marshood; Alsayed Khalil; Ahmad Settin; Issam Barrimah
Journal:  Int J Health Sci (Qassim)       Date:  2010-01

4.  RNA-Seq and ChIP-Seq reveal SQSTM1/p62 as a key mediator of JunB suppression of NF-κB-dependent inflammation.

Authors:  Xiaoling Zhang; Jane Y Jin; Joseph Wu; Xiaoxia Qin; Robert Streilein; Russell P Hall; Jennifer Y Zhang
Journal:  J Invest Dermatol       Date:  2014-12-16       Impact factor: 8.551

5.  CX3CR1 Deficiency Attenuates DNFB-Induced Contact Hypersensitivity Through Skewed Polarization Towards M2 Phenotype in Macrophages.

Authors:  Sayaka Otobe; Teruyoshi Hisamoto; Tomomitsu Miyagaki; Sohshi Morimura; Hiraku Suga; Makoto Sugaya; Shinichi Sato
Journal:  Int J Mol Sci       Date:  2020-10-07       Impact factor: 5.923

6.  CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis.

Authors:  Mariana D Batista; Camilla Tincati; Jeffrey M Milush; Emily L Ho; Lishomwa C Ndhlovu; Vanessa A York; Esper G Kallas; Jorge Kalil; Sheila M Keating; Philip J Norris; David Chang; Patrick Unemori; Kieron S Leslie; Toby Maurer; Wilson Liao; Douglas F Nixon
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 7.  Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis.

Authors:  Bogusław Nedoszytko; Małgorzata Sokołowska-Wojdyło; Katarzyna Ruckemann-Dziurdzińska; Jadwiga Roszkiewicz; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2014-04-22       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.